Skip to main content

Nantahala Capital Management, LLC

Position in APRE — Aprea Therapeutics, Inc.

CIK 1472322 New Canaan, CT

Position in APRE

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$165,019
+$8,025 QoQ
Shares Held
205,760
0.0% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 28 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. APRE ranks #52 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $165,019 205,760
2026-03-31 $156,994 205,760
2025-12-31 $175,513 205,760
2025-09-30 $303,496 205,760
2025-06-30 $347,734 205,760
2025-03-31 $419,750 205,760
2024-12-31 $676,950 205,760
2024-09-30 $565,840 205,760
2024-06-30 $837,443 205,760
2024-03-31 $1,376,534 205,760